PainReform (PainReform) Short-Term Capital Lease Obligation : $0.06 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PainReform Short-Term Capital Lease Obligation?

PainReform's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.06 Mil.

PainReform's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 ($0.06 Mil) to Dec. 2023 ($0.06 Mil) and increased from Dec. 2023 ($0.06 Mil) to Mar. 2024 ($0.06 Mil).

PainReform's annual Short-Term Capital Lease Obligation stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.06 Mil).

PainReform Short-Term Capital Lease Obligation Historical Data

The historical data trend for PainReform's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PainReform Short-Term Capital Lease Obligation Chart

PainReform Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.06

PainReform Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	0.06	0.06	0.06

PainReform Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

PainReform Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of PainReform's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

PainReform (PainReform) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PainReform Ltd (NAS:PRFX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Yigal Alon Street, Tel Aviv, ISR, 6744316

Website

https://www.painreform.com

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.